Kestra Medical Technologies, Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-117.6M | $15.3M |
| FY2024 | $42.5M | $-209.4M | $8.2M |
| FY2025 | $41.1M | $205.4M | $237.6M |
| FY2026 | $42.6M | $259.7M | $99.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-117.6M | $15.3M |
| FY2024 | $42.5M | $-209.4M | $8.2M |
| FY2025 | $41.1M | $205.4M | $237.6M |
| FY2026 | $42.6M | $259.7M | $99.7M |